[Prévia] [Próxima] [Prévia por assunto] [Próxima por assunto]
[Índice cronológico] [Índice de assunto]

[Fwd: JOB: PhD studentship at Sheffield University, UK]





-------- Original Message --------
Subject: JOB: PhD studentship at Sheffield University, UK
Date: Sat, 26 May 2007 13:48:43 +0100
From: Jeremy Oakley <j.oakley@SHEFFIELD.AC.UK>
Reply-To: Jeremy Oakley <j.oakley@SHEFFIELD.AC.UK>
To: allstat@JISCMAIL.AC.UK


Department of Probability and Statistics
University of Sheffield

Dorothy Hodgkin Postgraduate Award PhD Studentship 

Industrial sponsor: Roche Pharmaceuticals

Project title: Incorporating prior information into clinical trial planning
(see below for description)

Supervised by Dr Jeremy Oakley  

ELIGIBILITY

The studentship is only available to student nationals from India, China,
Hong Kong, South Africa, Brazil, Russia and the developing world, as defined
by the Development Assistance Committee of the OECD. A full list of eligible
countries can be found at
 
http://www.oecd.org/dataoecd/35/9/2488552.pdf

The eligible countries are all those in Part I of the list, plus Russia and
Hong Kong. With the exception of Russia and Hong Kong, none of the countries
in Part II of the list are eligible.


REQUIREMENTS

Candidates should hold a high-grade qualification, at least the equivalent
of a UK first class honours degree, from a prestigious academic institution.
Candidates should have a strong background in statistics and mathematics.
Some knowledge of Bayesian statistics would be desirable, but training will
be given as necessary. The project will involve a substantial computing
element and experience in a standard statistical computing environment will
be an advantage.

FEES AND MAINTENANCE GRANT	

The studentship covers full fees and a maintenance grant of 12,600 pounds
per year, for three years. Financial support may also be available in the
fourth year, if necessary.


APPLICATION PROCEDURE 

Informal enquiries can be made to Jeremy Oakley, j.oakley@shef.ac.uk,
tel: +44 (0) 114 222 3853 (direct line)

Applicants can submit a formal application by downloading an application
form from

http://www.shef.ac.uk/postgraduate/research/apply/index.html

Applications will be accepted until the studentship is filled. The studentship
will start on 24 September 2007.



PROJECT BACKGROUND

Both regulators and industry are increasingly aware of falling productivity
and the increasing cost of drug development. Expensive and unsuccessful
clinical trials can have serious consequences for the time taken for new and
better treatments to reach patients. When designing a clinical trial, it is
essential to consider the probability of any given trial design producing a
positive result. In assessing this probability, sponsors or decision-makers
in trial designs will typically only consider the power of the trial, i.e.
the conditional probability of a successful trial assuming a specified
treatment effect. Since the treatment effect is uncertain, this will not
provide a reliable assessment of the probability of a successful outcome and
can often give a misleading impression of the likely outcome of the trial.
As an alternative to using power, one can consider the unconditional
probability of a successful trial outcome that takes into account
uncertainty about how effective the treatment actually is. This
unconditional probability is known as the assurance.

To derive the assurance, the sponsor must consider any relevant prior
information about the treatment effect. A prior distribution is constructed
to represent this information, and then the unconditional probability of a
successful trial be obtained. Typically, the prior distribution is obtained
using expert elicitation. However, eliciting prior distributions is rarely a
straightforward task. Difficulties in eliciting reliable probability
distributions, even in simple cases, have been well documented and the
elicitation task can only be made more demanding in trials with more complex
outcome measures based on multiple endpoints. Despite the intuitive appeal
of assurance, decision-makers will not trust it as an aid to trial design
until they have confidence that prior knowledge can be formulated and
elicited reliably.
In this project we will explore the role of prior elicitation in clinical
trial planning, with the aim of designing robust elicitation producers such
that assurances can be assessed reliably.



Jeremy Oakley
Department of Probability and Statistics
University of Sheffield
The Hicks Building
Hounsfield Road
Sheffield S3 7RH, UK

Phone: +44 114 222 3853
Fax:   +44 114 222 3759

http://www.jeremy-oakley.staff.shef.ac.uk/